Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan-Feb;66(1):115-8.
doi: 10.1016/j.ihj.2013.12.024. Epub 2014 Jan 4.

Refractory atrial fibrillation effectively treated with ranolazine

Aditi Vaishnav  1 , Avani Vaishnav  1 , Yash Lokhandwala  2
Affiliations
Review

Refractory atrial fibrillation effectively treated with ranolazine

Aditi Vaishnav et al. Indian Heart J. 2014 Jan-Feb.

Abstract

Atrial fibrillation is the most common sustained cardiac arrhythmia which is often troublesome to manage. Currently, rhythm and rate control medications are the mainstays of therapy. In 2 amiodarone-refractory highly symptomatic patients, an innovative approach using ranolazine, which selectively acts on Na+ channels and delays atrial depolarization, was tried successfully.

Keywords: Anti-arrhythmic drugs; Arrhythmias; Cardioversion.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Update on ranolazine in the management of angina.
    Codolosa JN, Acharjee S, Figueredo VM. Codolosa JN, et al. Vasc Health Risk Manag. 2014 Jun 24;10:353-62. doi: 10.2147/VHRM.S40477. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 25028555 Free PMC article. Review.

References

    1. Haïssaguerre M., Jaïs P., Shah D. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–666. - PubMed
    1. Burashnikov A., Di Diego J.M., Zygmunt A.C. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation. 2007;116:1449–1457. - PMC - PubMed
    1. Murdock D., Overton N., Kersten M. The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation. Indian Pacing Electrophysiol J. 2008;8:175–181. - PMC - PubMed
    1. Fuster V., Ryden L.E., Cannom D.S. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2006;48:149–246. - PubMed
    1. Stewart S., Hart C.L., Hole D.J. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001;86:516–521. - PMC - PubMed

MeSH terms